Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
I was disappointd to see that the author of this article had chosen
to promote the very low QALY estimate submitted by Roche for the use of
Trastuzumab in early breast cancer. Even cursory reading of the NIHCE
guidance reveals that the Appraisal Committee concluded this to be an
underestimate and that the value was more likely to lie in the range
£16,000 - £33,000 per QALY.